Engineered phage with cell-penetrating peptides for intracellular bacterial infections

mSystems. 2023 Oct 26;8(5):e0064623. doi: 10.1128/msystems.00646-23. Epub 2023 Aug 18.

Abstract

Salmonella infection is a significant threat to global public health, and the increasing prevalence of antibiotic resistance exacerbates the situation. Therefore, finding new and effective ways to combat this pathogen is essential. Phages are natural predators of bacteria and can be used as an alternative to antibiotics to kill specific bacteria, including drug-resistant strains. One significant limitation of using phages as antimicrobial agents is their low cellular uptake, which limits their effectiveness against intracellular bacterial infections. Therefore, finding ways to enhance phage uptake is crucial. Our study provides a straightforward strategy for displaying cell-penetrating peptides on non-model phages, offering a promising novel and effective therapeutic approach for treating intracellular and drug-resistant bacteria. This approach has the potential to address the global challenge of antibiotic resistance and improve public health outcomes.

Keywords: cell-penetrating peptide; intracellular infection; phage engineering; phage therapy.

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Bacterial Infections* / therapy
  • Bacteriophages*
  • Cell-Penetrating Peptides*
  • Drug Resistance, Microbial
  • Humans

Substances

  • Cell-Penetrating Peptides
  • Anti-Bacterial Agents